Adenosine, glutamate and pH: Interactions and implications

Neurological Research

Volumn 27, Issue 2, 2005, Pages 149-152

  Masino, Susan A ^a   Dulla, Christopher G ^b  

^a TRINITY COLLEGE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUTAMIC ACID;

ANIMAL CELL; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; EXTRACELLULAR SPACE; HIPPOCAMPUS; MOLECULAR INTERACTION; NERVE EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PH; REVIEW; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; EXTRACELLULAR SPACE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; HYDROGEN-ION CONCENTRATION; SYNAPTIC TRANSMISSION;

EID: 15244352457     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X21850     Document Type: Review

References (66)

1. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Ann Rev Neurosci 2001; 24: 31-55
2. Thompson SM, Haas HL, Gahwiler BH. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol (Lond) 1992; 451: 347-363
3. Fredholm BB, Dunwiddie TV. How does adenosine inhibit transmitter release? Trends Pharmacol 1988; 9: 130-134
4. Dunwiddie TV, Fredholm BB. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther 1989; 249: 31-37
5. Fredholm BB, Ahlberg S, Altiok N, et al. Interactions between adenosine receptors and other membrane receptors. In: Imai, S., Nakazawa, M., eds, Role of Adenosine and Adenine Nucleotides in the Biological System. Amsterdam: Elsevier, 1991: pp. 173-182
6. Dixon AK, Gubitz AK, Sirinathsinghji DJ, et al. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 1996; 118: 1461-1468
7. Fredholm BB, Svenningsson P. Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology 2003; 61: S5-S9
8. Corsi C, Pinna A, Gianfriddo M, et al. Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats. Eur J Pharmacol 2003; 464: 33-38
9. Chen JF, Fredduzzi S, Bastia E, et al. Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease. Neurology 2003; 61: S74-S81
10. Chen JF, Moratalla R, Yu L, et al. Inactivation of adenosine A2A receptors selectively attenuates amphetamine-induced behavioral sensitization. Neuropsychopharmacol 2003; 28: 1086-1095
11. Alfinito PD, Wang SP, Manzino L, et al. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci 2003; 23: 10982-10987
12. Richardson PJ, Kase H, Jenner PG. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol 1997; 18: 338-344
13. Schwarzschild MA, Chen JF, Ascherio A. Caffeinated clues and the promise of adenosine A(2A) antagonists in PD. Neurology 2002; 58: 1154-1160
14. Schwarzschild MA, Xu K, Oztas E, et al. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology 2003; 61: S55-S61
15. Chen JF. The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment. Drug News Perspect 2003; 16: 597-604
16. Ikeda K, Kurokawa M, Aoyama S, et al. Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease. J Neurochem 2002; 80: 262-270
17. Billups B, Rossi D, Oshima T, et al. Physiological and pathological operation of glutamate transporters. Prog Brain Res 1998; 116: 45-57
18. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischemia is mainly by reversed uptake. Nature 2000; 403: 316-321
19. Simpson RE, O'Regan MH, Perkins LM, et al. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J Neurochem 1992; 58: 1683-1690
20. Wu LG, Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 1994; 12: 1139-1148
21. Moore KA, Nicoll RA, Schmitz D. Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 2003; 100: 14397-14402
22. Proctor WR, Dunwiddie TV. Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus. Brain Res 1987; 426: 187-190
23. Johansson B, Halldner L, Dunwiddie TV, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 2001; 98: 9407-9412
24. Aitken PG, Schiff SJ. Selective neuronal vulnerability to hypoxia in vitro. Neurosci Lett 1986; 67: 92-96
25. Mattson MP, Guthrie PB, Kater SB. Intrinsic factors in the selective vulnerability of hippocampal pyramidal neurons. Prog Clin Biol Res 1989; 317: 333-351
26. Dunwiddie TV. Adenosine and suppression of seizures. In: Delgado-Escueta, A, Wilson, WA, Olsen, RW, Porter, RJ, eds, Jasper's Basic Mechanisms of the Epilepsies, Philadelphia: Lippincott, Williams and Wilkins, 1999: pp. 1001-1010
27. Brundege JM, Dunwiddie TV. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci 1996; 16: 5603-5612
28. Dunwiddie TV, Diao LH. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J Pharmacol Exp Ther 1994; 268: 537-545
29. Gouder N, Fritschy JM, Boison D. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 2003; 44: 877-885
30. Boison D, Huber A, Padrun V et al. Seizure suppression by adenosine-releasing cells is independent of seizure frequency. Epilepsia 2002; 43: 788-796
31. Huber A, Padrun V, Deglon N, et al. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci USA 2001; 98: 7611-7616
32. Fowler JC. Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice. Naunyn-Schmied Arch Pharmacol 1993; 347: 73-78
33. Fowler JC. Purine release and inhibition of synaptic transmission during hypoxia and hypoglycemia in rat hippocampal slices. Neurosci Lett 1993; 157: 83-86
34. Phillis JW, Walter CA, O'Regan MH, et al. Increases in cerebral cortical perfusate adenosine and inosine concentrations during hypoxia and ischemia. J Cereb Blood Flow Metab 1987; 7: 679-686
35. Etherington LA, Frenguelli BG. Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner. Eur J Neurosci 2004; 19: 2539-2550
36. During MJ, Spencer DD. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Annl Neurol 1993; 32: 618-624
37. Geiger JD, Fyda DM. Adenosine transport in nervous system tissues. In: Stone, TW, ed., Adenosine in the Nervous System, London: Academic Press, 1991: pp. 1-20
38. Sinclair CJ, Shepel PN, Geiger JD, et al. Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation. Bioch Pharm 2000; 59: 477-483
39. Sperlagh B, Szabo G, Erdelyi F, et al. Homo- and heteroexchange of adenine nucleotides and nucleosides in rat hippocampal slices by the nucleoside transport system. Br J Pharmacol 2003; 139: 623-633
40. Manzoni OJ, Manabe T, Nicoll RA. Release of adenosine by activation of NMDA receptors in hippocampus. Science 1994; 265: 2098-2101
41. Masino SA, Dunwiddie TV. Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J Neurosci 1999; 19: 1932-1939
42. Gouder N, Scheurer L, Fritschy JM, et al. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 2004; 24: 692-701
43. Cunha RA, Vizi ES, Ribeiro JA, et al. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 1996; 67: 2180-2187
44. Cunha RA, Sebastiao AM, Ribeiro JA. Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci 1998; 18: 1987-1995
45. Dunwiddie TV, Diao L, Proctor WR. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 1997; 17: 7673-7682
46. Yamada Y, Goto H, Ogasawara N. Purification and properties of adenosine kinase from rat brain. Biochim Biophys Acta 1980; 616: 199-207
47. Newby AC. The pigeon heart 5′-nucleotidase responsible for ischaemia-induced adenosine formation. Biochem J 1988; 253: 123-130
48. Alrokayan S. Purification and characterization of adenosine deaminase from camel skeletal muscle. Int J Biochem Cell Biol 2002; 34: 1608-1618
49. Fillingame RH. Coupling H+ transport and ATP synthesis in F1F0-ATP synthases: glimpses of interacting parts in a dynamic molecular machine. J Exp Biol 1997; 200 (Pt 2): 217-224
50. Fykse EM, Fonnum F. Amino acid neurotransmission: dynamics of vesicular uptake. Neurochem Res 1996; 21: 1053-1060
51. Erecinska M, Nelson D, Dagani F, et al. Relations between intracellular ions and energy metabolism under acidotic conditions: a study with nigericin in synaptosomes, neurons, and C6 glioma cells. J Neurochem 1993; 61: 1356-1368
52. Bai L, Xu H, Collins JF, et al. Molecular and functional analysis of a novel neuronal vesicular glutamate transporter. J Biol Chem 2001; 276: 36764-36769
53. Lu Y, Chung HJ, Li Y, et al. NMDA receptor-mediated extracellular adenosine accumulation in rat forebrain neurons in culture is associated with inhibition of adenosine kinase. Eur J Neurosci 2003; 17: 1213-1222
54. Sperlagh B, Andras I, Vizi S. Effect of subtype-specific Ca(2+)-antagonists and Ca(2+)-free media on the field stimulation-evoked release of ATP and [3H]acetylcholine from rat habenula slices. Neurochem Res 1997; 22: 967-975
55. Dingledine R. N-methyl aspartate activates voltage-dependent calcium conductance in rat hippocampal pyramidal cells. J Physiol 1983; 343: 385-405
56. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev 2003; 83: 1183-1221
57. Elliott EM, Malouf AT, Catterall WA. Role of calcium channel subtypes in calcium transients in hippocampal CA3 neurons. J Neurosci 1995; 15: 6433-6444
58. Wei DS, Mei YA, Bagal A, et al. Compartmentalized and binary behavior of terminal dendrites in hippocampal pyramidal neurons. Science 2001; 293: 2272-2275
59. Engelman HS, MacDermott AB. Presynaptic ionotropic receptors and control of transmitter release. Nat Rev Neurosci 2004; 5: 135-145
60. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 2002; 3: 175-190
61. Agell N, Bachs O, Rocamora N, et al. Modulation of the Ras/Raf/ MEK/ERK pathway by Ca(2+), and calmodulin. Cell Signal 2002; 14: 649-654
62. Bito H, Takemoto-Kimura S. Ca(2+)/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival. Cell Calcium 2003; 34: 425-430
63. Chesler M, Kaila K. Modulation of pH by neuronal activity. Trends Neurosci 1992; 15: 396-402
64. Gauthier PM, Szerlip HM. Metabolic acidosis in the intensive care unit. Crit Care Clin 2002; 18: 289-308
65. Schwiening CJ, Willoughby D. Depolarization-induced pH microdomains and their relationship to calcium transients in isolated snail neurones. J Physiol 2002; 538: 371-382
66. Newby AC. Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem 1984; 9: 42-44